Top Markets
#1 Ontology Gas Ontology Gas +40.10%
#2 Verus Coin Verus Coin +22.50%
#3 EXOD EXOD +22.08%
#4 Status Status +19.99%
#5 Geodnet Geodnet +14.90%
#6 ETHGas ETHGas +13.90%
#7 The Black Bull The Black Bull +12.16%
#8 Fake World Assets Fake World Assets +11.14%
#9 Curve DAO Curve DAO +10.88%
#10 Pons Pons +10.54%
Coin of the day
Ontology Gas Ontology Gas
Settings
Language
ENGLISH
Currency
USD
Theme
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Rank in Stocks #25549
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Share Price
$20.01
Last synced: 2025-02-21
Market Cap
$48.36M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Singular Genomics Systems, Inc. (OMIC)

Category

Healthcare
Revenue for Singular Genomics Systems, Inc. (OMIC)
Revenue in Sep 2024 TTM: $2.67M
According to Singular Genomics Systems, Inc. latest financial reports the company's current revenue (TTM) is $2.67M. In 2022 the company made a revenue of $765.00K an increase over the revenue in the year 2021 that was 0.00. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Singular Genomics Systems, Inc. from 2019 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $2.67M -8.42%
2023 $2.91M 280.52%
2022 $765.00K 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B 413,793.47%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B 1,302,846.52%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B 781,557.91%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH